Cholecystokinin was one of the first gastrointestinal peptides discovered in the mammalian brain. In the central nervous system there is evidence for CCKA and CCKB receptor subtypes. The CCKA receptors occur in a few localized areas of the central and peripheral nervous systems where they modulate feeding and dopamine-induced behavior. CCKB receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. We have recently purified and cloned a CCKA receptor cDNA from rat pancreas that allowed isolation of an identical cDNA from rat brain by using the polymerase chain reaction. Using low-stringency hybridization screening of cDNA libraries from rat brain and AR42-J cells, which possess large numbers of CCKB receptors, we identified previously unreported cDNAs, the sequence of which were identical in both tissues. The cDNA sequence encodes a 452-amino acid protein that is 48% identical to the CCKA receptor and contains seven transmembrane domains characteristic of guanine nucleotide-binding regulatory protein-coupled receptors. COS-7 cells transfected with this cDNA expressed binding sites for agonists and antagonists characteristic of a CCKB receptor subtype. We conclude that this cDNA isolated from rat brain and AR42-J cells is a receptor of the CCKB subtype and that the respective cDNAs for both CCKA and CCKB are identical in the brain and gastrointestinal system. The cholecystokinin (CCK) family of peptides was originally isolated from the mammalian gastrointestinal tract (1) and was one of the first gastrointestinal peptides to be discovered in the brain (2, 3), where the predominant molecular form, cholecystokinin octapeptide (CCK-8), exists in sulfated and desulfated forms (2, 4).
ceptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. We have recently purified and cloned a CCKA receptor cDNA from rat pancreas that allowed isolation of an identical cDNA from rat brain by using the polymerase chain reaction. Using low-stringency hybridization screening of cDNA libraries from rat brain and AR42-J cells, which possess large numbers of CCKB receptors, we identified previously unreported cDNAs, the sequence of which were identical in both tissues. The cDNA sequence encodes a 452-amino acid protein that is 48% identical to the CCKA receptor and contains seven transmembrane domains characteristic of guanine nucleotide-binding regulatory protein-coupled receptors. COS-7 cells transfected with this cDNA expressed binding sites for agonists and antagonists characteristic of a CCKB receptor subtype. We conclude that this cDNA isolated from rat brain and AR42-J cells is a receptor of the CCKB subtype and that the respective cDNAs for both CCKA and CCKB are identical in the brain and gastrointestinal system. The cholecystokinin (CCK) family of peptides was originally isolated from the mammalian gastrointestinal tract (1) and was one of the first gastrointestinal peptides to be discovered in the brain (2, 3) , where the predominant molecular form, cholecystokinin octapeptide (CCK-8), exists in sulfated and desulfated forms (2, 4) .
The receptors for CCK in both the central nervous system (CNS) and peripheral tissues can be classified into two subtypes, CCKA and CCKB, on the basis of their affinity (i) for a structurally and functionally related family of peptides with identical COOH-terminal pentapeptide sequences and differing sulfation at the sixth (gastrin) and seventh (CCK) tyrosyl residues and (ii) for specific antagonists. CCKA receptors are highly selective (500-to 1000-fold higher affinity) for sulfated analogues and the antagonist L-364,718, whereas CCKB receptors have similarly high affinity for both sulfated and nonsulfated peptide analogues (only a 3-to 10-fold higher affinity for sulfated peptide analogues) and the antagonist L-365,260 (5) (6) (7) (8) .
A CCKA receptor subtype predominates in the gastrointestinal system but occurs also in highly localized areas of the rat CNS, where it modulates feeding and dopamine-induced behavior (9) (10) (11) . We recently purified the CCKA receptor and cloned its cDNA from rat pancreas (12) . This cDNA did not hybridize to poly(A)+ RNA from rat brain on Northern blot analysis, which raised the possibility that the rat brain CCK receptor with a CCKA receptor-subtype pharmacology was different from the rat pancreatic CCKA receptor (12) .
The CCKB receptor subtype is the predominant CCK receptor in the CNS, where it is widely distributed throughout the brain and spinal cord (10) . The presence of CCKB receptors on selective mesocorticolimbic dopaminergic neurons and other midbrain regions along with the effects of CCK analogues on behavior suggest that these receptors may modulate anxiety, neuroleptic activity, and arousal (11) . CCK agonists and antagonists acting at central CCKB receptors respectively block and enhance opiate-induced analgesia (13) . CCKB-type receptors have also been described outside the CNS in gastrointestinal smooth muscle cells (14) , where they modulate gallbladder and bowel motility; and in guinea pig (15) and dog pancreas (16) and various neoplastic tissues [such as human stomach, colon (17) , and lung carcinomas (18) , and the rat pancreatic acinar carcinoma cell line AR42-J (19) ], where they may regulate cell growth. The presence of CCKB receptors on peripheral lymphocytes and monocytes and monocyte-derived splenic cells suggests that CCK may play a role in the long-suspected neuroendocrine modulation of the immune system (20, 21) . To date, neither the CCKB receptor protein nor its cDNA has been isolated.
Here, we report that the cDNA encoding the rat pancreatic CCKA receptor is also present in rat brain and that both rat brain and AR42-J cells possess a distinctive cDNAt that is highly homologous to the rat CCKA receptor cDNA and encodes a guanine nucleotide-binding regulatory protein (G protein)-coupled receptor with CCKB receptor subtype pharmacology.
MATERIALS AND METHODS
cDNA Library Construction and Isolation of cDNA Clones. Total RNA was isolated from the rat pancreatic carcinoma cultured cell line AR42-J and from rat brain cortex by using a low-temperature guanidinium isothiocyanate/guanidine hydrochloride extraction procedure as described (22) , and poly(A)I RNA was isolated by using oligo(dT)-cellulose. Separate cDNA libraries were constructed from each source of poly(A)+ RNA. Oligo(dT)-primed cDNA > 2 kilobases (kb) was size-selected by agarose gel electrophoresis, electroeluted, adapted with EcoRI, ligated into phage AgtlO arms, and in vitro packaged by established methods (23) . Each library (-7.5 X 105 plaques) was screened with a 32P-labeled, randomly primed probe (24) 
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creas (12) initially under conditions of low and later high stringency [three 20-min agonist or antagonist. Cells were subsequently washed three times at 40C with 2 ml of PBS containing bovine serum albumin at 1 mg/ml by filtration on glass fiber filters (Whatman GF/C) with a suction manifold (Millipore). Filters were assayed for y radioactivity (Packard, Auto-Gamma).
RESULTS AND DISCUSSION
Although pharmacological studies of radiolabeled ligand binding to rat brain slices indicate several small discreet areas with receptors for CCK suggestive of a CCKA subtype (9), previous Northern blot hybridization studies using a 32p_ labeled, randomly primed full-length coding region probe of the CCKA receptor from rat pancreas did not identify a poly(A)+ RNA from rat brain cortex or subcortex (12) . To determine whether the rat brain contained the same CCKA receptor of the same subtype as the gastrointestinal CCKA receptor isolated from rat pancreas, we used primers flanking the coding region of the pancreatic CCKA receptor cDNA (12) and single-stranded cDNA from rat brain subcortex in a PCR to clone the rat brain CCKA receptor. This resulted in a single 1.4-kb product (data not shown) that was directly cycle-sequenced (Bethesda Research Laboratories) and found to have sequence identical to that of the rat pancreatic CCKA receptor cDNA (12) . PCR contamination from the previously cloned rat pancreatic cDNA was unlikely to account for this result because PCR reactions containing cDNA from cells not expressing CCKA receptors or lacking DNA target sequence did not result in an amplified product.
To obtain the rat brain CCKB receptor cDNA, we used the 32P-labeled, randomly primed full-length coding region of the CCKA receptor cDNA isolated from rat pancreas (12) to screen -7.5 x 105 plaques from two rat brain cDNA libraries constructed from cortex and subcortex under conditions of low and high stringency to isolate clones corresponding to pharmacologically described brain CCKB receptors (5) .
When this approach failed to yield any hybridizing plaques, we screened a cDNA library constructed from AR42-J cells, a rat pancreatic acinar carcinoma cell line known to express predominantly (80%o) CCKB-subtype CCK receptors pharmacologically identical to brain CCKB receptors (19) . Several candidate clones were isolated only under low-stringency conditions, two of which were sequenced and found to contain identical long open reading frames highly homologous to the CCKA receptor cDNA (data not shown).
To determine whether the nucleotide sequence of the candidate cDNA clones encoding CCKB receptors in AR42-J cells was the same as that encoding the CCKB receptors found in rat brain, we screened another 7.5 x 105 plaques from the rat brain cortex cDNA library, this time using the new CCKB open reading frame sequence as a 32P-labeled, randomly primed probe. Only high-stringency hybridizing clones were isolated, one of which was a 2243-base pair (bp) clone with identical cDNA sequence to those of the two clones isolated from the AR42-J cell cDNA library (Fig. 1). A comparison of the nucleotide sequence of the CCKB receptor cDNA to that of the CCKA receptor cDNA (Fig. 1 (12) , the sequence contains four potential N-linked glycosylation sites, three in the amino terminus and one in the third intracellular loop, which would account for the larger-than-predicted Mr of 90,000 from affinity crosslinking studies (19) . There is one potential site for protein kinase C phosphorylation, on serine-82 in the first intracellular loop and two potential sites for protein kinase A phosphorylation, on serine-154 in the second intracellular loop and serine-442 in the cytoplasmic tail (31) .
The predicted amino acid sequence of the CCKB receptor is 48% identical to the CCKA receptor (Fig. 2) , which is in the expected range for receptors within the same family (33, 36) (32) , rat neuromedin B receptor (33) , rat substance K receptor (34) , rat substance P receptor (34) , and rat neuromedin K receptor (35) , which further supports the suspected (19, 37) membership in the G-proteincoupled receptor superfamily (Fig. 2) . The homology between the two CCK receptor amino acid sequences diverge most notably in the length and composition of their third intracellular loops. This difference may contribute to a difference in G-protein coupling specificity, since this region has been shown to be important in G-protein coupling specificity of other receptors (38) Fig. 1 ).
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Proc. Natl. Acad. Sci. USA 89 (1992) ,-adrenergic, and muscarinic receptors (39) (40) (41) . A cysteine in the C-terminal region conserved in many of the G-proteincoupled receptors may be a membrane-anchoring palmitoylation site as demonstrated for rhodopsin and the 132-adrenergic receptors (42, 43) . An aspartate commonly found in the third transmembrane domain of charged amine-binding receptors is absent, as expected, in these peptide hormone receptors (38) .
Northern blot analysis revealed that the CCKA receptor cDNA probe hybridized to a single poly(A)I RNA of -2.7 kb from pancreas and AR42-J cells and 4.4 kb from guinea pig gallbladder, but not to mRNA from rat brain, striated muscle, liver, or kidney (Fig. 3 Upper) . The absence of hybridization to rat brain mRNA is not surprising for such a cellularly diverse tissue with CCKA receptors present only in small discreet areas and is consistent with the demonstrated need for the application ofPCR cloning when hybridization screening of a large number ofplaques from a rat brain cDNA library failed to detect any positive clones. The possibility of another more abundant brain CCK receptor with CCKA subtype pharmacology is unlikely in the absence of hybridization under conditions of low stringency (data not shown) but cannot be ruled out. High-stringency Northern blot hybridization to poly(A)+ RNA from the same tissues with a CCKB receptor cDNA probe (Fig. 3 Lower) revealed a single hybridizing transcript of -2.7 kb with the expected intensitỹ~~~~0 and distribution in rat brain subcortex, cortex (9) , and AR42-J cells (19) and absence of hybridization to mRNA from rat pancreas, striated muscle, kidney, or liver or from guinea pig gallbladder. The size of the hybridizing mRNA is close to the size of the CCKB receptor cDNA clones isolated from AR42-J cells.
To confirm that the two receptors cloned from rat brain correspond to the CCKA and CCKB receptor subtypes, pharmacologic characterization ofthe recombinant receptors expressed on COS-7 cells was performed. COS-7 cells transfected with the full-length cDNA inserts of either the CCKA (12) or CCKB (Fig. 1) receptor subcloned in the vector pCDL-SRa, were incubated with the radiolabeled ligand 125I-BH-CCK-8 alone or in the presence of increasing concentrations of unlabeled CCK receptor agonists or antagonists. In COS-7 cells transfected with the vector containing the CCKA receptor cDNA insert, CCK-8 was >1000 times as potent as gastrin-17-I in inhibiting binding of 125I-BH-CCK-8, and the CCKA receptor-specific antagonist L-364,718 was nearly equipotent to CCK-8 and 100 times more potent than the CCKB receptor-specific antagonist L-365,260 (Fig. 4 Upper). In COS-7 cells transfected with the vector containing the CCKB receptor cDNA insert, CCK-8 was only 3 times as potent as gastrin-17-I, and the CCKB receptor-specific antagonist L-365,260 was 30 times more potent than the CCKA receptor-specific antagonist L-364,718 in inhibiting 125I-BH-CCK-8 binding (Fig. 4 Lower). These results agree closely with previous pharmacological binding studies of CCKA and 
